中国生物医药产业发展水平综合评价及空间差异分析
    点此下载全文
引用本文:陈文俊1,彭有为1,贺正楚2,胡心怡1.中国生物医药产业发展水平综合评价及空间差异分析[J].财经理论与实践,2018,(3):147-154
摘要点击次数: 947
全文下载次数: 0
作者单位
陈文俊1,彭有为1,贺正楚2,胡心怡1 (1.中南林业科技大学 创新型企业风险管理与控制技术湖南省工程实验室湖南 长沙 4100042.长沙理工大学 经济管理学院湖南 长沙 410114) 
中文摘要:采用聚类分析法和空间自相关分析法,考量中国生物医药产业发展水平综合评价及空间差异。结果显示:中国生物医药产业发展水平差异显著,分布极不平衡,东部沿海省份生物医药产业发展水平较高,中部省份次之,大部分西部省份发展水平较低。中国生物医药产业发展水平呈现显著的空间正相关关系,呈现出明显的同类集聚现象。
中文关键词:生物医药产业  产业发展水平  空间差异  ESDA
 
Comprehensive Evaluation and Spatial Difference of Development Level of Biomedicine Industry in China
Abstract:First of all, the paper selected 26 indexes from aspects of scale and efficiency, scientific and technological innovation ability, development potential and so on, and built a comprehensive evaluation index system for the development level of biomedicine industry in our country at the base of these indexes. Then the method that is a combination of factor analysis and entropy weight method was used to make quantitative evaluation of the development level of biomedicine industry about 31 provinces. Finally, based on the quantitative evaluation results, the paper used cluster analysis and spatial autocorrelation analysis to analyze spatial differences of biomedicine industry in China. The results showed that there were significant differences in development level of biomedicine industry in our country, the distribution is also extremely unbalanced. The development level of biomedicine industry in the eastern coastal provinces is the highest, the central provinces followed, and the development level of most western provinces is the lowest. According to the values of comprehensive evaluation of Chinese biomedicine industry level, these biomedicine industry can be divided into five types: good, rather good, general, rather bad and bad type. Chinese biomedicine industry development level showed significant spatial positive correlation and a clear phenomenon of similar agglomeration.
keywords:biomedicine industry  the level of development  spatial difference  ESDA
查看全文   查看/发表评论   下载pdf阅读器